Work

A 12‐week, randomized, double‐blind, placebo‐controlled, four‐arm dose‐finding phase 2 study evaluating bexagliflozin as monotherapy for adults with type 2 diabetes

Year: 2019

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.13928

Authors: Yuan‐Di Halvorsen, Geoffrey Walford, Tara Thurber, Heidy Russell, Monica Massaro, Mason W. Freeman

Institutions: Massachusetts General Hospital, Center for Computational and Integrative Biology, Massachusetts General Hospital

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2990589793

FWCI: 1.421

Cites: 20

Cited by: 27

Related to: 10